李金磊,崔志新

多发性骨髓瘤（multiple myeloma，MM）以异常浆细胞和免疫蛋白的克隆增殖为特征，可导致溶骨性病变[1]。有多种影像学检查可以诊断和评估MM，常用的检查方法有CT、PET/CT、MRI等。

多发性骨髓瘤 ；疗效评估 ；双源双能CT ；MRI

[1] Rajkumar S V, Dimopoulos M A, Palumbo A, et al. International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma[J]. Lancet Oncol, 2014, 15(12): e538–e548. [2] Baffour FI, Glazebrook KN, Kumar SK, et al. Role of imaging in multiple myeloma[J]. Am J Hematol. 2020,95(8):966-977. [3] Pache G, Krauss B, Strohm P, et al. Dual-Energy CT Virtual Noncalcium Technique: Detecting Posttraumatic Bone Marrow Lesions—Feasibility Study[J]. Radiology, 2010, 256(2): 617–624. [4] Thomas C, Schabel C, Krauss B, et al. Dual-Energy CT: Virtual Calcium Subtraction for Assessment of Bone Marrow Involvement of the Spine in Multiple Myeloma[J]. AJR Am J Roentgenol, 2015, 204(3): W324–W331. [5] Fervers P, Celik E, Bratke G, et al. Radiotherapy Response Assessment of Multiple Myeloma: A Dual-Energy CT Approach With Virtual Non-Calcium Images[J]. Front Oncol, 2021, 11: 734819. [6] Hu C, Zhang Y, Xiong X, et al. Quantitative evaluation of bone marrow infiltration using dual-energy spectral computed tomography in patients with multiple myeloma[J]. J Xray Sci Technol, 2021, 29(3): 463–475 [7] Lecouvet FE.Whole-Body MR Imaging: Musculoskeletal Applications[J]. Radiology2016,279(2):345-365. [8] Moulopoulos L A, Dimopoulos M A, Christoulas D, et al. Diffuse MRI marrow pattern correlates with increased angiogenesis, advanced disease features and poor prognosis in newly diagnosed myeloma treated with novel agents[J]. Leukemia, 2010, 24(6): 1206–1212. [9] Dutoit J C, Vanderkerken M A, Verstraete K L. Value of whole body MRI and dynamic contrast enhanced MRI in the diagnosis, follow-up and evaluation of disease activity and extent in multiple myeloma[J]. Eur J Radiol, 2013, 82(9): 1444–1452. [10] Rana C, Sharma S, Agrawal V, et al. Bone marrow angiogenesis in multiple myeloma and its correlation with clinicopathological factors[J]. Ann Hematol, 2010, 89(8): 789–794. [11] Berardo S, Sukhovei L, Andorno S,et al. Quantitative bone marrow magnetic resonance imaging through apparent diffusion coefficient and fat fraction in multiple myeloma patients[J]. Radiol Med. 2021,126(3):445-452. [12] Filograna L, Magarelli N, Cellini F, et al. Diffusion weighted imaging (DWI) and apparent diffusion coefficient (ADC) values for detection of malignant vertebral bone marrow lesions[J]. Eur Rev Med Pharmacol Sci. 2018;22(3):590-597. [13] Giles S L, Messiou C, Collins D J, et al. Whole-Body Diffusion-weighted MR Imaging for Assessment of Treatment Response in Myeloma[J]. Radiology, 2014, 271(3): 785–794. [14] Cavo M, Terpos E, Nanni C, et al. Role of (18)F-FDG PET/CT in the diagnosis and management of multiplemyeloma and other plasma cell disorders: a consensus statement by the International Myeloma Working Group. Lancet Oncol, 2017. 18(4): p. e206-e217.

点击下载PDF